Crossref journal-article
Springer Science and Business Media LLC
Oncogene (297)
Bibliography

Todd, M. C., Sclafani, R. A., & Langan, T. A. (2000). Ovarian cancer cells that coexpress endogenous Rb and p16 are insensitive to overexpression of functional p16 protein. Oncogene, 19(2), 258–264.

Authors 3
  1. M C Todd (first)
  2. R A Sclafani (additional)
  3. T A Langan (additional)
References 46 Referenced 25
  1. Bartek J, Bartkova J and Lukas J . 1997 Exper Cell Res 237: 1–6. (10.1006/excr.1997.3776)
  2. Campbell IG, Beynon G, Davis M and Englefield P . 1995 Int J Cancer 63: 222–225. (10.1002/ijc.2910630213)
  3. Chenevix-Trench G, Kerr J, Friedlander MM, Hurst T, Sanderson B, Coglan M, Ward B, Leary J and Khoo SK . 1994 Am J Hum Genet 55: 143–149.
  4. Craig C, Kim M, Ohri E, Wersto R, Katayose D, Li Z, Choi YH, Mudahar B, Srivastava S, Seth P and Cowan K . 1998 Oncogene 16: 265–272. (10.1038/sj.onc.1201493)
  5. Dong Y, Walsh MD, McGuckin MA, Gabrielli BG, Cummings MG, Wright RG, Hurst T, Khoo SK and Parsons PG . 1997 Int J Cancer 74: 57–63. (10.1002/(SICI)1097-0215(19970220)74:1<57::AID-IJC10>3.0.CO;2-F)
  6. Fang X, Jin X, Xu H-J, Liu L, Peng H-Q, Hogg D, Roth JA, Yu Y, Xu F, Bast RC and Mills GB . 1998 Oncogene 16: 1–8. (10.1038/sj.onc.1201525)
  7. Gemma A, Takenoshita S, Hagiwara K, Okamoto A, Spillare EA, McMemamin MG, Hussain SP, Forrester K, Zariwala M, Xiong Y and Harris CC . 1996 Int J Cancer 68: 605–611. (10.1002/(SICI)1097-0215(19961127)68:5<605::AID-IJC9>3.0.CO;2-2)
  8. Geradts J, Kratzke RA, Niehans GA and Lincoln CE . 1995 Cancer Res 55: 6006–6011.
  9. Geradts J and Wilson PA . 1996 Am J Path 149: 15–20. (10.1108/03090599610105246)
  10. Gray-Bablin J, Zalvide J, Fox MP, Knickerbocker CJ, DeCaprio JA and Keyomarsi K . 1996 Proc Natl Acad Sci USA 93: 15215–15220. (10.1073/pnas.93.26.15215)
  11. He J, Olson JJ and James CD . 1995 Cancer Res 55: 4833–4836.
  12. Hinds PW, Mittnacht S, Dulic V, Arnold A, Reed SI and Weinberg RA . 1992 Cell 70: 993–1006. (10.1016/0092-8674(92)90249-C)
  13. Hung W-C, Chai C-Y, Huang J-S and Chuang L-Y . 1996 Human Path 27: 1324–1328. (10.1016/S0046-8177(96)90345-7)
  14. Jin X, Nguyen D, Zhang WW, Kyritsis AP and Roth JA . 1995 Cancer Res 55: 3250–3253.
  15. Kanuma T, Nishida J-I, Gima T, Barrett JC and Wake N . 1997 Molec Carcinog 18: 134–141. (10.1002/(SICI)1098-2744(199703)18:3<134::AID-MC2>3.0.CO;2-F)
  16. Krishan A . 1975 J Cell Biol 66: 188 (10.1083/jcb.66.1.188)
  17. Laemmli UK . 1970 Nature 227: 680–685. (10.1038/227680a0)
  18. Li SB, Schwartz PE, Lee W-H and Yang-Feng TL . 1991 J Natl Can Inst 83: 637–640. (10.1093/jnci/83.9.637)
  19. Liu Y, Heyman M, Wang Y, Falkmer U, Hising C, Szekely L and Einhorn S . 1994 Int J Cancer 58: 663–667. (10.1002/ijc.2910580508)
  20. Marchini S, Codegoni AM, Bonazzi C, Chiari S and Broggini M . 1997 Br J Cancer 76: 146–149. (10.1038/bjc.1997.355)
  21. McCluskey LL, Chen C, Delgadill E, Felix JC, Muderspach LI and Dubeau L . 1999 Gynecol Oncol 72: 87–92. (10.1006/gyno.1998.5235)
  22. Milde-Langosch K, Ocon E, Becker G and Loning T . 1998 Int J Can 79: 61–65. (10.1002/(SICI)1097-0215(19980220)79:1<61::AID-IJC12>3.0.CO;2-K)
  23. Nieman TH, Trgovac TL, McGaughy VR, Lewandowski GS and Copeland LJ . 1998 Gynecol Oncol 69: 214–219. (10.1006/gyno.1998.5015)
  24. Osborn RJ and Leach V . 1994 Br J Cancer 69: 429–438. (10.1038/bjc.1994.79)
  25. Otterson GA, Kratzke RA, Coxon A, Kim YW and Kaye FJ . 1994 Oncogene 9: 3375–3378.
  26. Palmero I and Peters G . 1997 Cancer Sur 27: 351–367. (10.1016/S0262-1762(99)80076-5)
  27. Radabaugh KJ, Biggs RB, Qureshi JA, Barrett AJ, Welch WR, Bell DA, Berkowitz RS and Mok SC . 1995 Oncogene 11: 1259–1254.
  28. Ryan A, Al-Jehani RM, Mulligan KT and Jacobs IJ . 1998 Gynecol Oncol 68: 14–17. (10.1006/gyno.1997.4881)
  29. Saito M, Helin K, Valentine MB, Griffith BB, William CL, Harlow E and Look AT . 1995 Genomics 25: 130–138. (10.1016/0888-7543(95)80118-6)
  30. Sakaguichi M, Fujii Y, Hirabayashi H, Yoon H-E, Komoto Y, Oue T, Kusafuka T, Okada A and Matsuda H . 1996 Int J Cancer 65: 442–445. (10.1002/(SICI)1097-0215(19960208)65:4<442::AID-IJC8>3.0.CO;2-X)
  31. Sclafani RA and Schauer IE . 1996 J Invest Derm 1: 123–127.
  32. Schultz DC, Vanderveer L, Buetow KH, Boente MP, Ozols RR, Hamilton TC and Godwin AK . 1995 Cancer Res 55: 2150–2157.
  33. Schuyer M, van Staveren IL, Klijn JGM, van der Burg MEL, Stoter G, Henzen-Logmans SC, Foekens JA and Berns EMJJ . 1996 Br J Cancer 74: 1069–1073. (10.1038/bjc.1996.491)
  34. Sellers WR and Kaelin WG . 1997 J Clin Oncol 15: 3301–3312. (10.1200/JCO.1997.15.11.3301)
  35. Serrano M, Hannon GJ and Beach D . 1993 Nature 366: 704–707. (10.1038/366704a0)
  36. Serrano M . 1997 Exper Cell Res 237: 7–13. (10.1006/excr.1997.3824)
  37. Sherr CJ . 1994 Cell 73: 1059–1065. (10.1016/0092-8674(93)90636-5)
  38. Shih Y-C, Kerr J, Liu J, Hurst T, Khoo S-K, Ward B, Wainwright B and Chenevix-Trench G . 1997 Int J Cancer 70: 508–511. (10.1002/(SICI)1097-0215(19970304)70:5<508::AID-IJC3>3.0.CO;2-1)
  39. Sui L, Tokuda M, Ohno M, Hatase O and Hando T . 1999 Gynecol, Oncol 73: 202–209. (10.1006/gyno.1999.5373)
  40. Taylor RR, Linnoila RI, Gerardts J, Teneriello MG, Nash JD, Park RC and Birrer MJ . 1995 Gynecol Oncol 58: 307–311. (10.1006/gyno.1995.1235)
  41. Weinberg RA . 1995 Cell 81: 323–311. (10.1016/0092-8674(95)90385-2)
  42. Weintraub S, Prater CA and Dean DC . 1992 Nature 358: 259–261. (10.1038/358259a0)
  43. Wolf JK, Kim T-E, Fightmaster D, Bodurka D, Gershenson DM Mills G and Wharton JT . 1999 Gynecol Oncol 73: 27–34. (10.1006/gyno.1998.5259)
  44. Wolfel T, Hauer M, Schneider J, Serrano M, Wolfel C, Klehmann-Hieb E, De Plaen E, Hankeln T, Meyer zum Buschenfelde K-H and Beach D . 1995 Science 269: 1281–1284. (10.1126/science.7652577)
  45. Worsley SD, Ponder BAJ and Davies BR . 1997 Gynecol Oncol 64: 189–195. (10.1006/gyno.1996.4569)
  46. Zuo L, Weger J, Yang Q, Goldstein AM, Tucker MA, Walker GJ, Hayward N and Dracopoli NC . 1996 Nature Genetics 12: 97–99. (10.1038/ng0196-97)
Dates
Type When
Created 23 years ago (Sept. 4, 2002, 3:45 p.m.)
Deposited 3 years, 5 months ago (March 21, 2022, 7:09 p.m.)
Indexed 1 month, 1 week ago (July 24, 2025, 8:26 a.m.)
Issued 25 years, 7 months ago (Jan. 13, 2000)
Published 25 years, 7 months ago (Jan. 13, 2000)
Published Online 25 years, 7 months ago (Jan. 20, 2000)
Published Print 25 years, 7 months ago (Jan. 13, 2000)
Funders 0

None

@article{Todd_2000, title={Ovarian cancer cells that coexpress endogenous Rb and p16 are insensitive to overexpression of functional p16 protein}, volume={19}, ISSN={1476-5594}, url={http://dx.doi.org/10.1038/sj.onc.1203289}, DOI={10.1038/sj.onc.1203289}, number={2}, journal={Oncogene}, publisher={Springer Science and Business Media LLC}, author={Todd, M C and Sclafani, R A and Langan, T A}, year={2000}, month=jan, pages={258–264} }